As of 2026-06-24, the Fair Value of 10X Genomics Inc (TXG) is -0.89 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 34.60 USD, the upside of 10X Genomics Inc is -102.58%.
With the market price of 34.60 USD and our fair value calculation, 10X Genomics Inc (TXG) is not a good investment. Investing in TXG stocks now will result in a potential loss of 102.58%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -58.20 | -166.00 | -255.10 | -182.63 | -43.54 | -141.09 |
| YoY growth | 89.28% | -185.22% | -53.67% | 28.41% | 76.16% | -9.01% |
| Market Cap (mil) | 4,392.82 |
| P/E | |
| Forward P/E |
| EPS | -0.18 |
| Avg earnings growth rate | -9.01% |
| TTM earnings | -22.66 |